Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 391, pseudogene (RN7SL391P) is classified as a pseudogene, meaning it is a non-functional sequence similar to the functional gene encoding 7SL RNA, the RNA component of the signal recognition particle (SRP)[6][1][5][7]. Pseudogenes like RN7SL391P arise from events such as retrotransposition or gene duplication, but they do not produce functional products[1][5][6]. While functional 7SL RNA plays a role in directing proteins to cellular membranes via the SRP complex[3][8], pseudogenes of 7SL RNA—of which there are hundreds dispersed throughout the human genome—are generally not transcribed into functional RNA and do not participate in biological processes or disease pathways[5][7]. There is no evidence that RN7SL391P is a therapeutic target, nor is it involved in signal transduction, immune response, or any recognized disease mechanism[1][5][6]. Summary: RN7SL391P is a non-coding RNA pseudogene and not a protein, enzyme, receptor, or any functional target relevant to drug development. No known drugs, mechanisms of action, biomarker roles, or disease associations have been described for this locus[1][6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 391, pseudogene (RN7SL391P).